Status:
UNKNOWN
Observing the Relationship of Fibroblast Growth Factor and Fibroblast in Thyroid Eye Disease
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Graves Ophthalmopathy
Eligibility:
All Genders
20-80 years
Brief Summary
Graves' orbitopathy (GO) affects about 50% of patients with Graves' disease (GD), and some cannot be cured by current treatments. Orbital fibroblasts involves in the pathogenesis of GO by producing gl...
Eligibility Criteria
Inclusion
- diagnosed as thyroid eye disease
- suggested to accept orbital decompression
Exclusion
- age below 20 or above 80
- pregnancy
Key Trial Info
Start Date :
December 25 2014
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 25 2020
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT03324022
Start Date
December 25 2014
End Date
December 25 2020
Last Update
October 31 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan University Hospital Taipei, Taiwan
Taipei, Taiwan